Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
Barton MI, MacGowan SA, Kutuzov MA, Dushek O, Barton GJ, van der Merwe PA. · 2021
Read Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. by Barton MI, MacGowan SA, Kutuzov MA, Dushek O, Barton GJ, van der Merwe PA. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8480977.txt.
Description
Barton and co-authors test how common mutations change the grip between the viral spike and its human receptor. SARS-CoV-2 must bind ACE2 to enter cells. Variants of concern carry changes in that binding domain. Human ACE2 itself also varies between people.
The team measured binding strength and speed for five spike mutations and two ACE2 changes. They tested single changes and the mixes found in the Alpha, Beta, and Gamma variants. Most spike changes tightened the bond. Two changes, at position 417, loosened it instead. The authors read N501Y and S477N as spread boosters. The 417 changes look more like immune escape moves.
Catalog record
| CREATOR | Barton MI, MacGowan SA, Kutuzov MA, Dushek O, Barton GJ, van der Merwe PA. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |